Public-Industry Alternative Working Models

Omega Araştırma provides consultancy services for the development of alternative working models that will positively support the reimbursement evaluation decisions of innovative drugs, that are compliant with legislation, applicable, proven effective and in which the public and the company can benefit together.

The consultancy service, in which alternative models are developed on a disease, indication and product basis, consists of 3 phases.